nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—CYCS—obesity	0.228	0.389	CbGaD
Minocycline—CASP1—obesity	0.228	0.389	CbGaD
Minocycline—IL1B—obesity	0.0763	0.13	CbGaD
Minocycline—SLC22A11—Cimetidine—obesity	0.0762	0.34	CbGbCtD
Minocycline—SLC22A7—Cimetidine—obesity	0.0726	0.324	CbGbCtD
Minocycline—MMP9—obesity	0.0539	0.0918	CbGaD
Minocycline—SLC22A8—Cimetidine—obesity	0.0443	0.198	CbGbCtD
Minocycline—SLC22A6—Cimetidine—obesity	0.0309	0.138	CbGbCtD
Minocycline—CASP3—ovarian follicle—obesity	0.00924	0.143	CbGeAlD
Minocycline—MMP9—tunica intima—obesity	0.00523	0.0807	CbGeAlD
Minocycline—CYCS—hindbrain—obesity	0.00233	0.036	CbGeAlD
Minocycline—CASP3—hindbrain—obesity	0.002	0.0308	CbGeAlD
Minocycline—IL1B—hindbrain—obesity	0.0016	0.0246	CbGeAlD
Minocycline—CYCS—islet of Langerhans—obesity	0.00151	0.0233	CbGeAlD
Minocycline—CASP1—respiratory system—obesity	0.00148	0.0228	CbGeAlD
Minocycline—CYCS—respiratory system—obesity	0.00143	0.022	CbGeAlD
Minocycline—CASP3—islet of Langerhans—obesity	0.00129	0.0199	CbGeAlD
Minocycline—CASP3—respiratory system—obesity	0.00122	0.0188	CbGeAlD
Minocycline—CASP1—cardiovascular system—obesity	0.00113	0.0175	CbGeAlD
Minocycline—CYCS—cardiovascular system—obesity	0.00109	0.0168	CbGeAlD
Minocycline—IL1B—islet of Langerhans—obesity	0.00103	0.0159	CbGeAlD
Minocycline—CASP3—adrenal cortex—obesity	0.00102	0.0158	CbGeAlD
Minocycline—VEGFA—islet of Langerhans—obesity	0.00102	0.0157	CbGeAlD
Minocycline—CASP1—pituitary gland—obesity	0.001	0.0155	CbGeAlD
Minocycline—CASP1—adipose tissue—obesity	0.001	0.0154	CbGeAlD
Minocycline—IL1B—respiratory system—obesity	0.000975	0.015	CbGeAlD
Minocycline—CASP1—digestive system—obesity	0.000941	0.0145	CbGeAlD
Minocycline—CASP3—cardiovascular system—obesity	0.000935	0.0144	CbGeAlD
Minocycline—CYCS—digestive system—obesity	0.000906	0.014	CbGeAlD
Minocycline—CASP1—adrenal gland—obesity	0.000897	0.0138	CbGeAlD
Minocycline—CYCS—adrenal gland—obesity	0.000863	0.0133	CbGeAlD
Minocycline—CASP3—pituitary gland—obesity	0.000828	0.0128	CbGeAlD
Minocycline—CASP3—adipose tissue—obesity	0.000824	0.0127	CbGeAlD
Minocycline—MMP9—respiratory system—obesity	0.000813	0.0125	CbGeAlD
Minocycline—VEGFA—adrenal cortex—obesity	0.000805	0.0124	CbGeAlD
Minocycline—CYCS—Mephentermine—Phentermine—obesity	0.000804	0.3	CbGdCrCtD
Minocycline—CASP1—endocrine gland—obesity	0.000778	0.012	CbGeAlD
Minocycline—CASP3—digestive system—obesity	0.000776	0.012	CbGeAlD
Minocycline—CYCS—endocrine gland—obesity	0.000749	0.0115	CbGeAlD
Minocycline—IL1B—cardiovascular system—obesity	0.000747	0.0115	CbGeAlD
Minocycline—CASP3—adrenal gland—obesity	0.000739	0.0114	CbGeAlD
Minocycline—CYCS—Mephentermine—Methamphetamine—obesity	0.000716	0.267	CbGdCrCtD
Minocycline—CASP1—liver—obesity	0.000701	0.0108	CbGeAlD
Minocycline—ALOX5—islet of Langerhans—obesity	0.00068	0.0105	CbGeAlD
Minocycline—CYCS—liver—obesity	0.000675	0.0104	CbGeAlD
Minocycline—IL1B—pituitary gland—obesity	0.000661	0.0102	CbGeAlD
Minocycline—IL1B—adipose tissue—obesity	0.000659	0.0102	CbGeAlD
Minocycline—VEGFA—pituitary gland—obesity	0.00065	0.01	CbGeAlD
Minocycline—VEGFA—adipose tissue—obesity	0.000648	0.00999	CbGeAlD
Minocycline—ALOX5—respiratory system—obesity	0.000642	0.00991	CbGeAlD
Minocycline—CASP3—endocrine gland—obesity	0.000641	0.00989	CbGeAlD
Minocycline—MMP9—cardiovascular system—obesity	0.000622	0.0096	CbGeAlD
Minocycline—IL1B—digestive system—obesity	0.00062	0.00956	CbGeAlD
Minocycline—IL1B—adrenal gland—obesity	0.000591	0.00911	CbGeAlD
Minocycline—VEGFA—adrenal gland—obesity	0.000581	0.00896	CbGeAlD
Minocycline—CASP3—liver—obesity	0.000578	0.00892	CbGeAlD
Minocycline—MMP9—adipose tissue—obesity	0.000549	0.00847	CbGeAlD
Minocycline—MMP9—digestive system—obesity	0.000517	0.00797	CbGeAlD
Minocycline—IL1B—endocrine gland—obesity	0.000512	0.0079	CbGeAlD
Minocycline—MMP9—adrenal gland—obesity	0.000492	0.00759	CbGeAlD
Minocycline—ALOX5—cardiovascular system—obesity	0.000492	0.00759	CbGeAlD
Minocycline—SLC22A11—digestive system—obesity	0.00049	0.00755	CbGeAlD
Minocycline—SLC22A7—digestive system—obesity	0.000478	0.00737	CbGeAlD
Minocycline—IL1B—liver—obesity	0.000462	0.00712	CbGeAlD
Minocycline—CYCS—Ethopropazine—Diethylpropion—obesity	0.000459	0.171	CbGdCrCtD
Minocycline—VEGFA—liver—obesity	0.000454	0.00701	CbGeAlD
Minocycline—ALOX5—adipose tissue—obesity	0.000434	0.00669	CbGeAlD
Minocycline—MMP9—endocrine gland—obesity	0.000427	0.00658	CbGeAlD
Minocycline—ALOX5—digestive system—obesity	0.000408	0.0063	CbGeAlD
Minocycline—SLC22A11—endocrine gland—obesity	0.000405	0.00624	CbGeAlD
Minocycline—SLC22A7—endocrine gland—obesity	0.000395	0.00609	CbGeAlD
Minocycline—ALOX5—adrenal gland—obesity	0.000389	0.006	CbGeAlD
Minocycline—MMP9—liver—obesity	0.000385	0.00594	CbGeAlD
Minocycline—SLC22A11—liver—obesity	0.000365	0.00563	CbGeAlD
Minocycline—SLC22A7—liver—obesity	0.000356	0.00549	CbGeAlD
Minocycline—ALOX5—endocrine gland—obesity	0.000338	0.00521	CbGeAlD
Minocycline—ALOX5—liver—obesity	0.000304	0.00469	CbGeAlD
Minocycline—CYCS—Alimemazine—Benzphetamine—obesity	0.000289	0.108	CbGdCrCtD
Minocycline—CYCS—Ethopropazine—Benzphetamine—obesity	0.000268	0.0999	CbGdCrCtD
Minocycline—CYCS—Tamoxifen—Benzphetamine—obesity	0.000143	0.0533	CbGdCrCtD
Minocycline—Methacycline—ALB—obesity	7.24e-05	0.695	CrCbGaD
Minocycline—Tetracycline—ALB—obesity	3.17e-05	0.305	CrCbGaD
Minocycline—CASP3—Signaling Pathways—CCL5—obesity	5.91e-06	4.86e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—DRD1—obesity	5.89e-06	4.84e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HTR2C—obesity	5.89e-06	4.84e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—COMT—obesity	5.88e-06	4.83e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NCF2—obesity	5.85e-06	4.81e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—STAT3—obesity	5.8e-06	4.76e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PPARGC1A—obesity	5.79e-06	4.76e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GNB3—obesity	5.79e-06	4.76e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—LPL—obesity	5.78e-06	4.75e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—HMOX1—obesity	5.77e-06	4.74e-05	CbGpPWpGaD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—AKT1—obesity	5.75e-06	4.73e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FOXO1—obesity	5.73e-06	4.71e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NTRK2—obesity	5.73e-06	4.71e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—RPS6KB1—obesity	5.72e-06	4.71e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ADRB1—obesity	5.71e-06	4.69e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NPY—obesity	5.7e-06	4.69e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PIK3CD—obesity	5.69e-06	4.68e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—APOC3—obesity	5.67e-06	4.66e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IAPP—obesity	5.67e-06	4.66e-05	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—ALB—obesity	5.65e-06	4.64e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GNAS—obesity	5.64e-06	4.64e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—ALB—obesity	5.62e-06	4.62e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—AKT2—obesity	5.6e-06	4.6e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GHRL—obesity	5.59e-06	4.59e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PARP1—obesity	5.59e-06	4.59e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—DRD4—obesity	5.54e-06	4.55e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—APOB—obesity	5.52e-06	4.54e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HTR1B—obesity	5.5e-06	4.52e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CRH—obesity	5.5e-06	4.52e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SDC1—obesity	5.44e-06	4.47e-05	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—IL6—obesity	5.41e-06	4.44e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—STAT3—obesity	5.4e-06	4.44e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—PIK3CD—obesity	5.38e-06	4.42e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PIK3R1—obesity	5.38e-06	4.42e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—NOS3—obesity	5.38e-06	4.42e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AKR1C3—obesity	5.35e-06	4.4e-05	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—PPARA—obesity	5.33e-06	4.38e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PRKCD—obesity	5.32e-06	4.37e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CNR1—obesity	5.29e-06	4.35e-05	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—IL6—obesity	5.29e-06	4.35e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—LPL—obesity	5.28e-06	4.34e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—MMP9—obesity	5.27e-06	4.33e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NPS—obesity	5.22e-06	4.29e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HTR2A—obesity	5.21e-06	4.28e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—C3—obesity	5.2e-06	4.28e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TCF7L2—obesity	5.2e-06	4.27e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—TYK2—obesity	5.17e-06	4.25e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—DRD2—obesity	5.16e-06	4.24e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—GPX1—obesity	5.15e-06	4.23e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HTR2C—obesity	5.12e-06	4.21e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—DRD1—obesity	5.12e-06	4.21e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PTPN1—obesity	5.11e-06	4.2e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GCG—obesity	5.11e-06	4.2e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—PIK3R1—obesity	5.08e-06	4.17e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CD36—obesity	5.01e-06	4.12e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TGFB1—obesity	5.01e-06	4.12e-05	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—APOA1—obesity	5e-06	4.11e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NTRK2—obesity	4.98e-06	4.09e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PIK3CB—obesity	4.96e-06	4.08e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ADRB1—obesity	4.95e-06	4.07e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IRS2—obesity	4.95e-06	4.07e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—AGT—obesity	4.94e-06	4.06e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PTGS2—obesity	4.92e-06	4.04e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—BCL2—obesity	4.89e-06	4.02e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PRL—obesity	4.87e-06	4.01e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PARP1—obesity	4.85e-06	3.99e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GHRL—obesity	4.85e-06	3.99e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—IFNG—obesity	4.84e-06	3.98e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—LEP—obesity	4.84e-06	3.98e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—APOE—obesity	4.84e-06	3.98e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—DRD4—obesity	4.81e-06	3.95e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—STK11—obesity	4.8e-06	3.95e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CAV1—obesity	4.8e-06	3.94e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—APOA1—obesity	4.79e-06	3.93e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PLG—obesity	4.75e-06	3.91e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—MTHFR—obesity	4.75e-06	3.9e-05	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—ALB—obesity	4.75e-06	3.9e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—STAT3—obesity	4.69e-06	3.85e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—MTOR—obesity	4.69e-06	3.85e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—PIK3CB—obesity	4.69e-06	3.85e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TNF—obesity	4.67e-06	3.84e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PPARA—obesity	4.66e-06	3.83e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FOXO3—obesity	4.64e-06	3.81e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ADRB2—obesity	4.62e-06	3.8e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—ESR1—obesity	4.62e-06	3.8e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CNR1—obesity	4.59e-06	3.78e-05	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—IL6—obesity	4.59e-06	3.77e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—PIK3CA—obesity	4.57e-06	3.76e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—F2—obesity	4.57e-06	3.75e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PRKCB—obesity	4.57e-06	3.75e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SOCS1—obesity	4.55e-06	3.74e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—AGT—obesity	4.51e-06	3.71e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TCF7L2—obesity	4.51e-06	3.71e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—BAD—obesity	4.51e-06	3.71e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SOCS3—obesity	4.5e-06	3.7e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—DRD2—obesity	4.48e-06	3.68e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PTPN1—obesity	4.44e-06	3.65e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GCG—obesity	4.44e-06	3.65e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—APOE—obesity	4.42e-06	3.63e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GNB3—obesity	4.4e-06	3.62e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CAV1—obesity	4.38e-06	3.6e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—APOA1—obesity	4.37e-06	3.59e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PIK3CG—obesity	4.37e-06	3.59e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TGFB1—obesity	4.35e-06	3.57e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IGF2—obesity	4.33e-06	3.56e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IRS1—obesity	4.32e-06	3.55e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—GNAS—obesity	4.29e-06	3.53e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TGFB1—obesity	4.26e-06	3.5e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PRL—obesity	4.23e-06	3.48e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—APOB—obesity	4.2e-06	3.45e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—PIK3CA—obesity	4.19e-06	3.44e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—STK11—obesity	4.17e-06	3.43e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—POMC—obesity	4.16e-06	3.42e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—INS—obesity	4.14e-06	3.4e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PLG—obesity	4.12e-06	3.39e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCL5—obesity	4.1e-06	3.37e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—CCL2—obesity	4.07e-06	3.35e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TNF—obesity	4.06e-06	3.34e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—IL6—obesity	4.05e-06	3.33e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FOXO3—obesity	4.03e-06	3.31e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ADRB2—obesity	4.01e-06	3.3e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—LPL—obesity	4.01e-06	3.3e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IGF1—obesity	4e-06	3.29e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—AKT2—obesity	4e-06	3.29e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PIK3CG—obesity	3.99e-06	3.28e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FOXO1—obesity	3.98e-06	3.27e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RPS6KB1—obesity	3.97e-06	3.27e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—MAPK8—obesity	3.96e-06	3.26e-05	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—ALB—obesity	3.96e-06	3.26e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SOCS1—obesity	3.95e-06	3.25e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SOCS3—obesity	3.91e-06	3.21e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PPARG—obesity	3.85e-06	3.17e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PIK3CD—obesity	3.84e-06	3.16e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GNB3—obesity	3.82e-06	3.14e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—SERPINE1—obesity	3.8e-06	3.12e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—POMC—obesity	3.8e-06	3.12e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—INS—obesity	3.78e-06	3.11e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—IL6—obesity	3.77e-06	3.1e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IGF2—obesity	3.76e-06	3.09e-05	CbGpPWpGaD
Minocycline—CASP1—Immune System—AKT1—obesity	3.73e-06	3.07e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—GNAS—obesity	3.72e-06	3.06e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TYK2—obesity	3.7e-06	3.04e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PRKCD—obesity	3.69e-06	3.04e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—RHOA—obesity	3.67e-06	3.01e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—APOB—obesity	3.65e-06	3e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—PIK3CA—obesity	3.63e-06	2.98e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PIK3R1—obesity	3.63e-06	2.98e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—NOS3—obesity	3.63e-06	2.98e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—STAT3—obesity	3.62e-06	2.98e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HTR2A—obesity	3.62e-06	2.97e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—C3—obesity	3.61e-06	2.97e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCL5—obesity	3.56e-06	2.93e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PIK3CD—obesity	3.51e-06	2.88e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—LPL—obesity	3.48e-06	2.86e-05	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—AKT1—obesity	3.48e-06	2.86e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—ALB—obesity	3.46e-06	2.85e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FOXO1—obesity	3.46e-06	2.84e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RPS6KB1—obesity	3.45e-06	2.84e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IRS2—obesity	3.43e-06	2.82e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AGT—obesity	3.43e-06	2.82e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—APOE—obesity	3.36e-06	2.76e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—LEP—obesity	3.36e-06	2.76e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MTOR—obesity	3.35e-06	2.75e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PIK3CB—obesity	3.35e-06	2.75e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CAV1—obesity	3.33e-06	2.74e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—APOA1—obesity	3.32e-06	2.73e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PIK3R1—obesity	3.31e-06	2.72e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—NOS3—obesity	3.31e-06	2.72e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—IL6—obesity	3.27e-06	2.69e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—ESR1—obesity	3.21e-06	2.64e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PRKCD—obesity	3.21e-06	2.64e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—F2—obesity	3.17e-06	2.61e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PRKCB—obesity	3.17e-06	2.61e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HTR2A—obesity	3.14e-06	2.58e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—C3—obesity	3.13e-06	2.58e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—BAD—obesity	3.13e-06	2.57e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PIK3CB—obesity	3.06e-06	2.51e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PIK3CG—obesity	3.03e-06	2.49e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PTGS2—obesity	3.03e-06	2.49e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—PIK3CA—obesity	3.03e-06	2.49e-05	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—AKT1—obesity	3.02e-06	2.48e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IRS1—obesity	3e-06	2.46e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IRS2—obesity	2.98e-06	2.45e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AGT—obesity	2.98e-06	2.45e-05	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—AKT1—obesity	2.96e-06	2.44e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—APOE—obesity	2.92e-06	2.4e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—LEP—obesity	2.92e-06	2.4e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MMP9—obesity	2.91e-06	2.39e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CAV1—obesity	2.89e-06	2.38e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—POMC—obesity	2.89e-06	2.37e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—APOA1—obesity	2.88e-06	2.37e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—INS—obesity	2.87e-06	2.36e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—PIK3CA—obesity	2.86e-06	2.35e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MAPK8—obesity	2.83e-06	2.33e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—CCL2—obesity	2.83e-06	2.32e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—ESR1—obesity	2.79e-06	2.29e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IGF1—obesity	2.78e-06	2.28e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AKT2—obesity	2.78e-06	2.28e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—F2—obesity	2.75e-06	2.26e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PRKCB—obesity	2.75e-06	2.26e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—BAD—obesity	2.72e-06	2.23e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PIK3CD—obesity	2.67e-06	2.19e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—SERPINE1—obesity	2.64e-06	2.17e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PIK3CG—obesity	2.63e-06	2.16e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IRS1—obesity	2.6e-06	2.14e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—STAT3—obesity	2.59e-06	2.13e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TYK2—obesity	2.57e-06	2.11e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—RHOA—obesity	2.54e-06	2.09e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—IL6—obesity	2.53e-06	2.08e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PIK3R1—obesity	2.52e-06	2.07e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—NOS3—obesity	2.52e-06	2.07e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—POMC—obesity	2.51e-06	2.06e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—INS—obesity	2.49e-06	2.05e-05	CbGpPWpGaD
Minocycline—CYCS—Metabolism—AKT1—obesity	2.47e-06	2.03e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—CCL2—obesity	2.45e-06	2.02e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IGF1—obesity	2.41e-06	1.98e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AKT2—obesity	2.41e-06	1.98e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MYC—obesity	2.4e-06	1.98e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TGFB1—obesity	2.4e-06	1.97e-05	CbGpPWpGaD
Minocycline—IL1B—Immune System—AKT1—obesity	2.33e-06	1.92e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PIK3CB—obesity	2.32e-06	1.91e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MTOR—obesity	2.32e-06	1.91e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PIK3CD—obesity	2.31e-06	1.9e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—SERPINE1—obesity	2.29e-06	1.88e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TYK2—obesity	2.23e-06	1.83e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—RHOA—obesity	2.21e-06	1.82e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—NOS3—obesity	2.19e-06	1.8e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PIK3R1—obesity	2.19e-06	1.8e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—PIK3CA—obesity	2.04e-06	1.68e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MTOR—obesity	2.02e-06	1.66e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PIK3CB—obesity	2.02e-06	1.66e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MAPK8—obesity	1.96e-06	1.62e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—PIK3CA—obesity	1.86e-06	1.53e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—IL6—obesity	1.81e-06	1.49e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—STAT3—obesity	1.8e-06	1.48e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MMP9—obesity	1.75e-06	1.44e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MAPK8—obesity	1.71e-06	1.4e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MYC—obesity	1.67e-06	1.37e-05	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—AKT1—obesity	1.67e-06	1.37e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TGFB1—obesity	1.67e-06	1.37e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—STAT3—obesity	1.56e-06	1.28e-05	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—AKT1—obesity	1.52e-06	1.25e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MYC—obesity	1.45e-06	1.19e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TGFB1—obesity	1.45e-06	1.19e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—PIK3CA—obesity	1.42e-06	1.16e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—IL6—obesity	1.25e-06	1.03e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—PIK3CA—obesity	1.23e-06	1.01e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AKT1—obesity	1.16e-06	9.51e-06	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—IL6—obesity	1.09e-06	8.95e-06	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AKT1—obesity	1e-06	8.26e-06	CbGpPWpGaD
